AB

Albert Bourla

Albert Bourla, PhD


Chief Executive Officer


New York, New York, United States



Professional Overview
Dr. Albert Bourla is the Chief Executive Officer of Pfizer, one of the world's premier biopharmaceutical companies. With over 30 years of experience in the pharmaceutical industry, he has deep expertise in developing and commercializing innovative medicines that address unmet medical needs globally. As CEO, Dr. Bourla provides strategic leadership and oversees the company's efforts to advance groundbreaking science and deliver life-changing therapies to patients worldwide.

Experience Summary

Current Role
As Chief Executive Officer of Pfizer (since 2019), Dr. Bourla is responsible for setting the company's overall vision and strategy, driving innovation, and ensuring the successful execution of Pfizer's mission to develop breakthroughs that change patients' lives. Under his leadership, Pfizer has accelerated the development and manufacturing of its COVID-19 vaccine, which has played a critical role in the global pandemic response. Additionally, Dr. Bourla has championed Pfizer's commitment to environmental sustainability and social responsibility, positioning the company as a leader in corporate citizenship.

Career Progression
Prior to becoming CEO, Dr. Bourla held several senior leadership roles at Pfizer, including Group President of Pfizer Innovative Health, Group President of Vaccines, Oncology, and Consumer Healthcare, and President and General Manager of the Established Products Business Unit. Throughout his career, he has demonstrated a track record of driving business growth, fostering innovation, and building high-performing teams.

Academic Background
Dr. Bourla holds a Doctor of Veterinary Medicine (DVM) degree from the Aristotle University of Thessaloniki in Greece and a PhD in the Biotechnology of Reproduction from the Veterinary School of Aristotle University.

Areas of Expertise
  • Pharmaceutical industry leadership and strategy

  • Research and development of innovative medicines

  • Global commercial operations and market expansion

  • Organizational transformation and change management

  • Driving sustainable business practices and corporate responsibility


Professional Impact
Under Dr. Bourla's leadership, Pfizer has continued to be at the forefront of the biopharmaceutical industry, delivering groundbreaking therapies and contributing to advancements in global public health. His strategic vision and focus on innovation have positioned the company to address some of the world's most pressing healthcare challenges.

Conclusion
With his extensive experience, deep scientific expertise, and transformative leadership, Dr. Albert Bourla is well-equipped to guide Pfizer in its mission to develop and deliver innovative medicines that improve and extend the lives of patients worldwide. His commitment to driving scientific progress, fostering a culture of excellence, and promoting sustainable business practices make him a highly respected and influential figure in the pharmaceutical industry.